KEGG   DRUG: Vandefitemcel
Entry
D13083                      Drug                                   
Name
Vandefitemcel (INN);
SB623;
hMSC-SB623
Efficacy
Promoting proliferation and differentiation of nerve cells agent
  Type
Cellular therapy product
Comment
Human differentiation-restricted descendents (DRCs) of bone-marrow-derived adherent stromal cells (MASCs) isolated from adult donor. To obtain DRCs, MASCs were transiently transfected with a DNA plasmid encoding human Notch-1 intracellular domain (NICD) and expanded in growth media.
Brite
New drug approvals in Japan [br08318.html]
 Cellular and gene therapy products
  D13083
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D13083
Other DBs
PubChem: 507530398
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system